{"id":"W2042692879","doi":"10.1002/cncr.22996","title":"A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Prostate cancer; Placebo; Urology; Peripheral edema; Hazard ratio; Oncology; Adverse effect; Gastroenterology; Randomized controlled trial; Surgery; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001092618,0.0001613537,0.001276772,0.0001215416,0.00003503331,0.000004757175,0.0000646386,0.00003842257,0.0000723114],"category_scores_gemma":[0.0001317523,0.00007424372,0.0001454591,0.0002887609,0.0004654368,0.00004752603,0.00002213859,0.0001728205,1.914963e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001908078,"about_ca_system_score_gemma":0.000598189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006148194,"about_ca_topic_score_gemma":0.0001985894,"domain_scores_codex":[0.9983899,0.0001685898,0.000590848,0.0001957069,0.0003915767,0.0002633802],"domain_scores_gemma":[0.9986752,0.0005889965,0.0003034954,0.0001953633,0.0001362053,0.0001007909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9779065,0.0008632513,0.001030776,0.0001142705,0.0008730047,0.00002490568,0.001135837,0.00001037543,0.00944222,0.00001751927,0.00008457607,0.008496815],"study_design_scores_gemma":[0.988068,0.001185887,0.002187674,0.000324601,0.0007712598,0.000002521577,0.0002599649,0.00009209351,0.006793891,0.0000167774,0.000217675,0.00007964339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730443,0.01641505,0.00001543732,0.0005498705,0.00007280053,0.008877139,0.00005292186,0.000006902862,0.0009655844],"genre_scores_gemma":[0.9887708,0.009265165,0.00003807636,0.00004261735,0.00006052855,0.0006890856,0.000006541711,0.00001804984,0.001109077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01572657,"threshold_uncertainty_score":0.3027571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01891782803452224,"score_gpt":0.3564106759370143,"score_spread":0.3374928479024921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}